SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
EXELIXIS
(NQNM:EXEL Last Sale: 25.63 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (EXEL : $25.63)
$7,835,950 million Market Cap at Market Close, July 1, 2022
Employs 520.
Biomedics SubIndustry up .00% / Health Industry up .00% Today
210 East Grand Avenue Research Report Earnings Snapshot - Last 11/04/18
P.O. Box 511 Fact Sheet
South San Francisco, CA 94080 Financial Statements
Phone: (650) 837-7000 Peer Comparison
Fax: (650) 825-2205 Annual Reports

S. Papadopoulos, Chmn., George A. Scangos, Pres./CEO, Frank Karbe, CFO
Uses model system genetics and comparative genomics in the development of drugs, insecticides, and animal health products. IPO at $13 April 10, 2000. Raised $118.3 million, selling 9.1 million shares, 21% of the outstanding. Lead Manager: Goldman Sachs.
Historical Charts    Technical Analysis
No Historical Data available for EXEL

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common EXEL $25.63 $25.63 0 .0 $24.01 $25.66 4,097,596 $24.01 $25.66 305,733,496
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock #############

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex